# Hypertonic Lactate After Cardiac Arrest

Study · id `cardio:ct-nct05004610` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05004610](<https://clinicaltrials.gov/study/NCT05004610>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05004610

Browse, organ or system: Heart  
Browse, condition area: Acute care and long-term living  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 125 participants.

## Technical summary

Registry record NCT05004610. Randomized; single masking; primary purpose treatment. Start 2025-02-19 (actual); primary completion 2027-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 125 participants (planned count; ClinicalTrials.gov record NCT05004610, source copy `cardio:ctgov-nct05004610-2025-02-21`, retrieved 2026-10-26)
- Started: 2025-02-19 (actual) (ClinicalTrials.gov record NCT05004610, source copy `cardio:ctgov-nct05004610-2025-02-21`, retrieved 2026-10-26)
- Primary completion: 2027-12-31 (anticipated) (ClinicalTrials.gov record NCT05004610, source copy `cardio:ctgov-nct05004610-2025-02-21`, retrieved 2026-10-26)
- Completion: 2028-05-15 (anticipated) (ClinicalTrials.gov record NCT05004610, source copy `cardio:ctgov-nct05004610-2025-02-21`, retrieved 2026-10-26)
- Countries: Belgium (ClinicalTrials.gov record NCT05004610, source copy `cardio:ctgov-nct05004610-2025-02-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05004610-2025-02-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: Hypertonic Lactate After Cardiac Arrest
- Acronym: LATTE
- Condition: Cardiac Arrest
- Condition: Ischemia Reperfusion Injury
- Condition: Anoxic Brain Injury
- Intervention (Drug): Sodium Lactate Solution
- Lead sponsor: Erasme University Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Sudden cardiac arrest (`cardio:sudden-cardiac-arrest`)
- Registry lists this organization as the lead sponsor: Erasme University Hospital (`cardio:org-erasme-university-hospital`)

## Provenance

Content hash: 4f288d9253f34c669dfe9403e3878669ac38d6fc6c887b65690eb101405ab1f3
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
